Whitehawk Therapeutics (WHWK) Revenue (2018 - 2025)

Whitehawk Therapeutics (WHWK) has 7 years of Revenue data on file, last reported at $7.1 million in Q1 2025.

• Revenue for Q1 2025 came in at $7.1 million, up 33.48% year-over-year; the trailing twelve-month figure through Dec 2025 was $7.1 million (down 72.5% YoY), and the FY2025 annual result was $7.1 million, down 72.5% from the prior year.
• Revenue retreated to $7.1 million in Q1 2025 per WHWK's latest filing, from $7.2 million in the prior quarter.
• Over five years, Revenue peaked at $14.0 million in Q4 2021 and troughed at $120000.0 in Q1 2021.
• A 5-year average of $5.8 million and a median of $6.0 million in 2023 frame the typical range for Revenue.
• On a YoY basis, Revenue climbed as much as 1822.5% in 2022 and fell as far as 62.66% in 2022.
• A 5-year view of Revenue shows it stood at $14.0 million in 2021, then plunged by 62.66% to $5.2 million in 2022, then increased by 21.03% to $6.3 million in 2023, then gained by 14.43% to $7.2 million in 2024, then decreased by 1.3% to $7.1 million in 2025.
• Business Quant data shows WHWK's Revenue at $7.1 million in Q1 2025, $7.2 million in Q4 2024, and $7.2 million in Q3 2024.